Systemic effects of ingested lactobacillus rhamnosus: Inhibition of mast cell membrane potassium (IKCA) current and degranulation

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Forsythe, Paul ^a   Wang, Binxiang ^a   Khambati, Ibrahim ^a   Kunze, Wolfgang A ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA N ACETYLHEXOSAMINIDASE; CALCIUM ACTIVATED POTASSIUM CHANNEL; IMMUNOGLOBULIN E; JB 1; LACTOBACILLUS RHAMNOSUS EXTRACT; PROBIOTIC AGENT; UNCLASSIFIED DRUG;

ALLERGIC REACTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTHMA; BACTERIAL STRAIN; CALCIUM CELL LEVEL; CALCIUM CONDUCTANCE; CELL ACTIVATION; CELLULAR IMMUNITY; COCULTURE; CONTROLLED STUDY; EFFECTOR CELL; ELECTROPHYSIOLOGY; IMMUNOMODULATION; LACTOBACILLUS RHAMNOSUS; MAST CELL; MAST CELL DEGRANULATION; NONHUMAN; PASSIVE SKIN ANAPHYLAXIS; PATCH CLAMP; PERITONEUM MAST CELL; POTASSIUM CURRENT; RAT; SENSORY NERVE CELL; STEADY STATE; SUPERNATANT;

ANIMALS; CALCIUM; CELL MEMBRANE; COCULTURE TECHNIQUES; ELECTROPHYSIOLOGY; IMMUNOGLOBULIN E; INTERMEDIATE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS; INTESTINES; LACTOBACILLUS RHAMNOSUS; MAST CELLS; PATCH-CLAMP TECHNIQUES; PERITONEUM; POTASSIUM; POTASSIUM CHANNELS; PROBIOTICS; RATS; RATS, SPRAGUE-DAWLEY;

ANIMALIA; LACTOBACILLUS; LACTOBACILLUS RHAMNOSUS; RATTUS;

EID: 84863992212     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0041234     Document Type: Article

References (49)

1. Forsythe P, Inman MD, Bienenstock J, (2007) Oral treatment with live Lactobacillus reuteri inhibits the allergic airway response in mice. Am J Respir Crit Care Med 175: 561-569.
2. Forsythe P, Bienenstock J, (2010) Immunomodulation by commensal and probiotic bacteria. Immunol Invest 39: 429-448.
3. Kawase M, He F, Kubota A, Harata G, Hiramatsu M, (2010) Oral administration of lactobacilli from human intestinal tract protects mice against influenza virus infection. Lett Appl Microbiol 51: 6-10.
4. Feleszko W, Jaworska J, Rha RD, Steinhausen S, Avagyan A, et al. (2007) Probiotic-induced suppression of allergic sensitization and airway inflammation is associated with an increase of T regulatory-dependent mechanisms in a murine model of asthma. Clin Exp Allergy 37: 498-505.
5. Inoue R, Nishio A, Fukushima Y, Ushida K, (2007) Oral treatment with probiotic Lactobacillus johnsonii NCC533 (La1) for a specific part of the weaning period prevents the development of atopic dermatitis induced after maturation in model mice, NC/Nga. Br J Dermatol 156: 499-509.
6. Kim JY, Choi YO, Ji GE, (2008) Effect of oral probiotics (Bifidobacterium lactis AD011 and Lactobacillus acidophilus AD031) administration on ovalbumin-induced food allergy mouse model. J Microbiol Biotechnol 18: 1393-1400.
7. Hisbergues M, Magi M, Rigaux P, Steuve J, Garcia L, et al. (2007) In vivo and in vitro immunomodulation of Der p 1 allergen-specific response by Lactobacillus plantarum bacteria. Clin Exp Allergy 37: 1286-1295.
8. Baba N, Samson S, Bourdet-Sicard R, Rubio M, Sarfati M, (2009) Selected commensal-related bacteria and Toll-like receptor 3 agonist combinatorial codes synergistically induce interleukin-12 production by dendritic cells to trigger a T helper type 1 polarizing programme. Immunology 128: e523-31.
9. Iwabuchi N, Takahashi N, Xiao JZ, Yonezawa S, Yaeshima T, et al. (2009) Suppressive effects of Bifidobacterium longum on the production of Th2-attracting chemokines induced with T cell-antigen-presenting cell interactions. FEMS Immunol Med Microbiol 55: 324-334.
10. Kwon HK, Lee CG, So JS, Chae CS, Hwang JS, et al. (Feb 2) Generation of regulatory dendritic cells and CD4+ Foxp3+ T cells by probiotics administration suppresses immune disorders. Proc Natl Acad Sci U S A 107: 2159-2164.
11. Schiffer C, Lalanne AI, Cassard L, Mancardi DA, Malbec O, et al. (2011) A strain of Lactobacillus casei inhibits the effector phase of immune inflammation. J Immunol 187: 2646-2655.
12. Moon TC, St Laurent CD, Morris KE, Marcet C, Yoshimura T, et al. (2010) Advances in mast cell biology: new understanding of heterogeneity and function. Mucosal Immunol 3: 111-128.
13. Maurer M, Theoharides T, Granstein RD, Bischoff SC, Bienenstock J, et al. (2003) What is the physiological function of mast cells? Exp Dermatol 12: 886-910.
14. Vliagoftis H, Befus AD, (2005) Rapidly changing perspectives about mast cells at mucosal surfaces. Immunol Rev 206: 190-203.
15. Rivera J, Olivera A, (2008) A current understanding of Fc epsilon RI-dependent mast cell activation. Curr Allergy Asthma Rep 8: 14-20.
16. Karimi K, Inman MD, Bienenstock J, Forsythe P, (2009) Lactobacillus reuteri-induced regulatory T cells protect against an allergic airway response in mice. Am J Respir Crit Care Med 179: 186-193.
17. Kunze WA, Mao YK, Wang B, Huizinga JD, Ma XJ, et al. (2007) A Lactobacillus modulates peristalsis and a specific ion channel in gut sensory neurons. submitted to Science.
18. Ma D, Forsythe P, Bienenstock J, (2004) Live Lactobacillus reuteri is essential for the inhibitory effect on tumor necrosis factor alpha-induced interleukin-8 expression. Infect Immun 72: 5308-5314.
19. Bravo JA, Forsythe P, Chew MV, Escaravage E, Savignac HM, et al. (2011) Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci U S A 108: 16050-16055.
20. Vancanneyt M, Huys G, Lefebvre K, Vankerckhoven V, Goossens H, et al. (2006) Intraspecific genotypic characterization of Lactobacillus rhamnosus strains intended for probiotic use and isolates of human origin. Appl Environ Microbiol 72: 5376-5383.
21. Kamiya T, Wang L, Forsythe P, Goettsche G, Mao Y, et al. (2006) Inhibitory effects of Lactobacillus reuteri on visceral pain induced by colorectal distension in Sprague-Dawley rats. Gut 55: 191-196.
22. Bissonnette EY, Befus AD, (1990) Inhibition of mast cell-mediated cytotoxicity by IFN-alpha/beta and-gamma. J Immunol 145: 3385-3390.
23. Schwartz LB, Austen KF, (1980) Enzymes of the mast cell granule. J Invest Dermatol 74: 349-353.
24. Katayama S, Shionoya H, Ohtake S, (1978) A new method for extraction of extravasated dye in the skin and the influence of fasting stress on passive cutaneous anaphylaxis in guinea pigs and rats. Microbiol Immunol 22: 89-101.
25. Duffy SM, Cruse G, Lawley WJ, Bradding P, (2005) Beta2-adrenoceptor regulation of the K + channel iKCa1 in human mast cells. FASEB J 19: 1006-1008.
26. Mark Duffy S, Berger P, Cruse G, Yang W, Bolton SJ, et al. (2004) The K + channel iKCA1 potentiates Ca2+ influx and degranulation in human lung mast cells. J Allergy Clin Immunol 114: 66-72.
27. Mao Y, Wang B, Kunze W, (2006) Characterization of myenteric sensory neurons in the mouse small intestine. J Neurophysiol 96: 998-1010.
28. Hille B, (1984) Ionic channels of excitable membranes. Massachusetts: Sunderland.
29. Rugiero F, Gola M, Kunze WA, Reynaud JC, Furness JB, et al. (2002) Analysis of whole-cell currents by patch clamp of guinea-pig myenteric neurones in intact ganglia. J Physiol 538: 447-463.
30. Koda A, Miura T, Inagaki N, Sakamoto O, Arimura A, et al. (1990) A method for evaluating anti-allergic drugs by simultaneously induced passive cutaneous anaphylaxis and mediator cutaneous reactions. Int Arch Allergy Appl Immunol 92: 209-216.
31. Oskeritzian C, Peronet R, Prouvost-Danon A, David B, (1993) In vivo assessment of mast cell functional alteration induced by L-leucine methyl ester, using the passive cutaneous anaphylaxis technique. Int Arch Allergy Immunol 100: 56-59.
32. Kunze WA, Mao YK, Wang B, Huizinga JD, Ma X, et al. (2009) Lactobacillus reuteri enhances excitability of colonic AH neurons by inhibiting calcium dependent potassium channel opening. J Cell Mol Med 13: 2261-70.
33. Lyons A, O'Mahony D, O'Brien F, MacSharry J, Sheil B,et al. (May) Bacterial strain-specific induction of Foxp3+ T regulatory cells is protective in murine allergy models. Clin Exp Allergy 40: 811-819.
34. Oksaharju A, Kankainen M, Kekkonen RA, Lindstedt KA, Kovanen PT, et al. (2011) Probiotic Lactobacillus rhamnosus downregulates FCER1 and HRH4 expression in human mast cells. World J Gastroenterol 17: 750-759.
35. Schiffer C, Lalanne AI, Cassard L, Mancardi DA, Malbec O, et al. (2011) A strain of Lactobacillus casei inhibits the effector phase of immune inflammation. J Immunol 187: 2646-2655.
36. Magerl M, Lammel V, Siebenhaar F, Zuberbier T, Metz M, et al. (2008) Non-pathogenic commensal Escherichia coli bacteria can inhibit degranulation of mast cells. Exp Dermatol 17: 427-435.
37. Shumilina E, Lam RS, Wolbing F, Matzner N, Zemtsova IM, et al. (2008) Blunted IgE-mediated activation of mast cells in mice lacking the Ca2+-activated K + channel KCa3.1. J Immunol 180: 8040-8047.
38. Bradding P, (2005) Mast cell ion channels. Chem Immunol Allergy 87: 163-178.
39. Knudsen T, (1995) The Na+/K(+)-pump in rat peritoneal mast cells: some aspects of regulation of activity and cellular function. Dan Med Bull 42: 441-454.
40. Nemeth A, Magyar P, Huszti Z, (1990) Inhibition of potassium-induced release of histamine from mast cells by tetraethylammonium and tetramethylammonium. Agents Actions 30: 143-145.
41. Cruse G, Duffy SM, Brightling CE, Bradding P, (2006) Functional KCa3.1 K + channels are required for human lung mast cell migration. Thorax 61: 880-885.
42. Duffy SM, Cruse G, Brightling CE, Bradding P, (2007) Adenosine closes the K + channel KCa3.1 in human lung mast cells and inhibits their migration via the adenosine A2A receptor. Eur J Immunol 37: 1653-1662.
43. Duffy SM, Cruse G, Cockerill SL, Brightling CE, Bradding P, (2008) Engagement of the EP2 prostanoid receptor closes the K + channel KCa3.1 in human lung mast cells and attenuates their migration. Eur J Immunol 38: 2548-2556.
44. Beeton C, Wulff H, Barbaria J, Clot-Faybesse O, Pennington M, et al. (2001) Selective blockade of T lymphocyte K (+) channels ameliorates experimental autoimmune encephalomyelitis, a model for multiple sclerosis. Proc Natl Acad Sci U S A 98: 13942-13947.
45. Chandy KG, Wulff H, Beeton C, Pennington M, Gutman GA, et al. (2004) K + channels as targets for specific immunomodulation. Trends in Pharmacological Sciences 25: 280-289.
46. Wulff H, Beeton C, Chandy KG, (2003) Potassium channels as therapeutic targets for autoimmune disorders. Curr Opin Drug Discov Devel 6: 640-647.
47. Wulff H, Knaus HG, Pennington M, Chandy KG, (2004) K + channel expression during B cell differentiation: implications for immunomodulation and autoimmunity. J Immunol 173: 776-786.
48. Eisenhut M, Wallace H, (2011) Ion channels in inflammation. Pflugers Arch 461: 401-421.
49. Bradding P, Wulff H, (2009) The K + channels K(Ca)3.1 and K(v)1.3 as novel targets for asthma therapy. Br J Pharmacol 157: 1330-1339.